These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8194708)

  • 1. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2.
    Michitaka K; Durazzo M; Tillmann HL; Walker D; Philipp T; Manns MP
    Gastroenterology; 1994 Jun; 106(6):1603-10. PubMed ID: 8194708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.
    Seelig R; Renz M; Bünger G; Schröter H; Seelig HP
    Clin Exp Immunol; 1993 Jun; 92(3):373-80. PubMed ID: 8390333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
    Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
    Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies.
    Gerotto M; Pontisso P; Giostra F; Francesconi R; Muratori L; Ballardini G; Lenzi M; Tisminetzky S; Bianchi FB; Baralle FB
    J Hepatol; 1994 Aug; 21(2):273-6. PubMed ID: 7989722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-GOR and hepatitis C virus in autoimmune liver diseases.
    Michel G; Ritter A; Gerken G; Meyer zum Büschenfelde KH; Decker R; Manns MP
    Lancet; 1992 Feb; 339(8788):267-9. PubMed ID: 1346282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
    Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
    J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.
    Manns MP; Griffin KJ; Sullivan KF; Johnson EF
    J Clin Invest; 1991 Oct; 88(4):1370-8. PubMed ID: 1717511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
    Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
    Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.
    Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M
    J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruses and autoimmune liver disease.
    Manns MP
    Intervirology; 1993; 35(1-4):108-15. PubMed ID: 8407237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HCV-RNA in paraffin-embedded liver biopsies from patients with autoimmune hepatitis.
    Savage K; Dhillon AP; Schmilovitz-Weiss H; el-Batanony M; Brown D; Dusheiko G; Scheuer PJ
    J Hepatol; 1995 Jan; 22(1):27-34. PubMed ID: 7751584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
    Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
    J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
    Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
    Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-GOR in hepatitis D: specific association with hepatitis C virus superinfection.
    Durazzo M; Michel G; Philipp T; Braun HB; Luttig B; Rizzetto M; Manns M
    Int J Clin Lab Res; 1994; 24(4):227-9. PubMed ID: 7894050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden. Swedish Internal Medicine Liver club.
    Lindgren S; Braun HB; Michel G; Nemeth A; Nilsson S; Thome-Kromer B; Eriksson S
    Scand J Gastroenterol; 1997 Feb; 32(2):175-8. PubMed ID: 9051879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].
    Durazzo M; Costa C; Schmidt E; Loges S; Scaglione L; Touscoz AG; Smedile A; Manns MP; Rizzetto M; Pagano G
    Ann Ital Med Int; 1995; 10(2):93-7. PubMed ID: 7542466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.
    Löhr HF; Schlaak JF; Lohse AW; Böcher WO; Arenz M; Gerken G; Meyer Zum Büschenfelde KH
    Hepatology; 1996 Dec; 24(6):1416-21. PubMed ID: 8938173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.